Covid-19: Don’t Abuse Dexamethasone – FDA
The Food and Drugs Authority (FDA) has warned the general public against buying dexamethasone without prescription following news of the drug helping to reduce the number of mortalities in Covid-19 patients on ventilators and oxygen in the UK.
The FDA in a statement cautioned that the drug does not treat Covid-19 in persons who are asymptomatic or mild to moderately ill with the results of the recovery trial in the UK, only proving to be effective for preventing some deaths in terminally ill patients.
The authority said in their statement, “Dexamethasone should therefore not under any circumstances be used for the prevention of Covid-19 as its potential to suppress the immune system will counteract the body’s natural function to fight against Covid-19 and other infections in the long term”.
With many different countries experimenting with various treatment mechanisms, the UK’s announcement of the findings from its dexamethasone use has generated conversations in other countries with calls for its use in other places.